Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lunai Bioworks Inc. - Common Stock (NQ:RENB)

0.1617 -0.0032 (-1.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,643,388
Open 0.1786
Bid (Size) 0.1700 (52)
Ask (Size) 0.1791 (50)
Prev. Close 0.1649
Today's Range 0.1600 - 0.1786
52wk Range 0.1649 - 2.100
Shares Outstanding 172,118,569
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lunai Bioworks subsidiary BioSymetrics and Brigham and Women’s Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics
Via ACCESS Newswire
Top 3 Health Care Stocks You'll Regret Missing In Q3
 
Via Benzinga

Performance

YTD
-78.8%
-78.8%
1 Month
-30.1%
-30.1%
3 Month
-52.9%
-52.9%
6 Month
-78.8%
-78.8%
1 Year
-73.3%
-73.3%

More News

Read More
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
Via ACCESS Newswire
Lunai Bioworks Strengthens European Strategy Through Restructuring
Via ACCESS Newswire
Lunai Bioworks Inc. Retains American Defense International
Via ACCESS Newswire
Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics
Via ACCESS Newswire
PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
From Kahn Swick & Foti, LLC
Via GlobeNewswire
Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks
Via ACCESS Newswire
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector
Via ACCESS Newswire
Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy
Via ACCESS Newswire
Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives
Via ACCESS Newswire
These stocks are moving in today's after hours session
Via Chartmill
Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs
Via ACCESS Newswire
Tuesday's session: gap up and gap down stocks
Via Chartmill
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
From Renovaro Inc
Via GlobeNewswire
Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish
Via Stocktwits
Topics Artificial Intelligence Lawsuit
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
From Renovaro Inc
Via GlobeNewswire
Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics
From Renovaro Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
From Renovaro Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
From Renovaro Inc
Via GlobeNewswire
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire

Frequently Asked Questions

Is Lunai Bioworks Inc. - Common Stock publicly traded?
Yes, Lunai Bioworks Inc. - Common Stock is publicly traded.
What exchange does Lunai Bioworks Inc. - Common Stock trade on?
Lunai Bioworks Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lunai Bioworks Inc. - Common Stock?
The ticker symbol for Lunai Bioworks Inc. - Common Stock is RENB on the Nasdaq Stock Market
What is the current price of Lunai Bioworks Inc. - Common Stock?
The current price of Lunai Bioworks Inc. - Common Stock is 0.1617
When was Lunai Bioworks Inc. - Common Stock last traded?
The last trade of Lunai Bioworks Inc. - Common Stock was at 09/18/25 04:00 PM ET
What is the market capitalization of Lunai Bioworks Inc. - Common Stock?
The market capitalization of Lunai Bioworks Inc. - Common Stock is 27.83M
How many shares of Lunai Bioworks Inc. - Common Stock are outstanding?
Lunai Bioworks Inc. - Common Stock has 28M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.